Kellie founded Symmetry Capital Management, a health-care focused hedge fund, in October 2001. For nearly, 20 years, Symmetry Capital has focused on small to mid-capitalization biotechnology and medical device companies. In 2020, Symmetry’s limited partnerships will begin investment in the cannabis industry, through Medicus LP, as a complimentary sector with far more near-term upside potential.

Ms. Seringer has 25 years of public, health care equity experience. Prior to founding Symmetry Capital, she had been a portfolio manager for the EGM Medical Technology Fund in 2000 and 2001. For the year 2000, the strategy was the 5th overall ranked hedge fund, as reported in January 2001 by Barron’s. Prior to EGM, she held equity research analyst positions at Evolution Capital, Montgomery Securities, now Bank of America Securities, and Dean Witter Reynolds.

Philanthropy is an important aspect to Ms. Seringer’s life. She has been the President of Friends of Harvey Milk from 2010 – 2019. The Friends of Harvey Milk focuses on funding youth projects central to the mission of equity, academics and social justice in the spirit of the work and life of Harvey Milk, who dedicated his life to creating social justice and equity for all. Additionally, she has been a CASA (Court Appointed Special Advocate) in San Francisco for over 10 years and has two daughters who were formerly in foster care. Ms. Seringer has also served as the President of multiple 501(c)3 school foundations over the last decade.

Ms. Seringer graduated from Texas A&M University with Bachelor of Science degrees in Biochemistry and Genetics.